RxDoctor Payments Data

Kara Nabbout, APRN

Family · Wichita, KSNPI 1497330005

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 222 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 30.6% of the total. Reporting peaked in 2024 at $1,692 and has fallen 54.3% since, to $773 in 2025. Among family clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,795in general payments, 2019–2025

Across 222 payments — averaging $26.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • E.r. Squibb & Sons, L.L.C.$672
  • Johnson & Johnson$472
  • Sanofi$392
  • Amgen$370
  • Pfizer$340
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$5,72699%
  • Education$691%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,795 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$185,253
Medicare patients
539
Services billed
2,093

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate72$2,181
Tacrolimus19$1,812
Fluorouracil16$1,371
Metronidazole11$1,129
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc18$780
Doxycycline Monohydrate23$692
Ketoconazole37$674
Triamcinolone Acetonide97$571
CiclopiroxCiclopirox Olamine16$458
Clindamycin Phosphate12$211
Mupirocin12$83
ValacyclovirValacyclovir Hcl14$70
Minoxidil11$45
Fluconazole13$38

Paid to pharmacies, not to this prescriber.

Other family in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →